First published online 12 September 2007
doi: 10.1242/dev.009308
Development 134, 3603-3613 (2007)
Published by The Company of Biologists 2007
Independent functions and mechanisms for homeobox gene Barx1 in patterning mouse stomach and spleen
Byeong-Moo Kim1,2,
Isabelle Miletich3,
Junhao Mao4,
Andrew P. McMahon4,
Paul A. Sharpe3 and
Ramesh A. Shivdasani1,2,5,*
1 Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115,
USA.
2 Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
3 Department of Craniofacial Development, Dental Institute, Kings College,
London SE1 9RT, UK.
4 Department of Molecular and Cellular Biology, Harvard University, Cambridge,
MA 02138, USA.
5 Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115,
USA.

View larger version (108K):
[in this window]
[in a new window]
|
Fig. 1. Gastrointestinal homeosis in the absence of Barx1. (A)
Comparison of the differences in size and morphology of normal (left) and
Barx1-/- (right) neonatal stomach, as observed in dozens
of embryos and newborn mice. Es, esophagus; St, stomach; Du, duodenum.
(B,D) Mucosal differences between normal (D) and
Barx1-/- neonatal (B) stomach, revealing a crowded
villiform epithelium in the latter. (C) Low-magnification micrograph of
PAS staining of Barx1-/- neonatal stomach, shown to reveal
the boundary within the stomach (dotted line) of strongly PAS+
gastric mucosa proximally and largely PAS- intestinal epithelium
distally. (E-G) Normal epithelial histology (H&E stain) from the
neonatal mouse forestomach (E), corpus (F) and antrum (G). (H,I)
Gross architectural disorganization typifies the abnormal epithelium (H&E
stain) of Barx1-/- neonatal mid-stomach. (J-O)
Histochemical (PAS and Alcian Blue) and molecular [Pdx1, Cdx2, gastric
intrinsic factor (If) and trefoil factor 3 (Tff3)] stains highlight the sharp
boundary (dotted line) between epithelia of the gastric (top in J-M, left in
N,O) and intestinal (bottom in J-M, right in N,O) types in
Barx1-/- stomach. J-M represent consecutive tissue
sections, and N-O are consecutive to each other but not to the others.
|
|

View larger version (72K):
[in this window]
[in a new window]
|
Fig. 2. Severe mucosal abnormalities in the proximal foregut of
Barx1-/- mice. (A,B) Abnormally proximal
expression of Pdx1 (near the squamous lining) and mixing of
H+/K+-ATPase+ and Pdx1+ cells in
the glandular mucosa of Barx1-/- neonatal stomach. The two
panels show staining on adjacent sections. (C) Radial asymmetry of the
most-proximal mucosa, with one surface lined by a flat squamoid epithelium
(seen at the top of the image) and the other (bottom) by a cuboidal epithelium
containing many ciliated cells (arrows). (D,E) PAS (D) and
Muc5ac staining (E) reveal the presence in both surfaces of cuboidal cells
with features of glandular pit cells. (F) Ultastructural confirmation
of numerous apical cilia in cells lining neonatal Barx1-/-
proximal foregut. (G,H) Immunohistochemical evidence for
expression of Sox2, a squamous foregut marker, shown at low (G) and high (H)
magnification. (I,J) Smooth muscle actin staining indicates
smooth muscle differentiation in Barx1-/- stomach (J),
although both signal strength and tissue continuity are reduced in comparison
to littermate controls (I). (K) Graphic representation of
gastrointestinal homeotic and regional anomalies that occur in the absence of
Barx1.
|
|

View larger version (121K):
[in this window]
[in a new window]
|
Fig. 3. In vivo confirmation that Barx1 enables attenuation of Wnt signaling in
prospective stomach epithelium. (A,B) lacZ staining
in Barx1-/-;TOPGALTg (B) and control
Barx1+/-;TOPGALTg (A) mouse fetal stomach at
E16.5, when endogenous Wnt signaling is virtually abolished and there is no
esophageal activity (dashed lines) in control embryos but strong signals
remain in Barx1 mutants. (C,D) Histochemical
confirmation of persistent ß-gal activity in rostral
Barx1-/-;TOPGALTg stomach endoderm (D,
arrowheads) in relation to negligible signal in corresponding
Barx1+/-;TOPGALTg tissue (C).
(E,F) Further confirmation by lacZ in situ
hybridization of mRNA persistence in rostral E16.5
Barx1-/-;TOPGAL stomach endoderm (F), which contrasts with
the absence of expression in control E16.5 Barx1+/+;TOPGAL
tissue (E). (G-I) Persistent Wnt signaling is further revealed by
nuclear localization of ß-catenin in the emerging squamous epithelium of
Barx1-/- (G, boxed area shown at higher magnification in
H) but not control (I) foregut. (J,K) Similarly, ß-gal
activity persists in E18.5 Barx1-/-;Axin2lacZ
fetal stomach (K) compared with
Barx1+/-;Axin2lacZ controls (J). Dashed and
solid lines in A and J demarcate normal esophagus (Es) and duodenum (Du),
respectively. St, stomach; fore, forestomach; hind, hind-stomach (the blurred
boundaries between fore- and hindstomach are represented by dotted lines).
Scale bars: 75 µm in C; 60 µm in D; 75 µm in E,F.
|
|

View larger version (121K):
[in this window]
[in a new window]
|
Fig. 4. Independent confirmation of the adverse effects of unregulated Wnt
signaling in developing stomach endoderm. Findings in E18.5
ShhCre/+;Catnb+/lox(ex3) mouse embryos.
(A,B) Constitutive ß-catenin activation is confirmed by its
nuclear staining (A), compared with membrane staining in areas that escaped
Cre-mediated recombination (B). (C-E) The stomach is reduced in size
and lined by a crowded, villiform epithelium (C,E; H&E stain) that shares
features seen in Barx1 mutant stomach, including thick folds and
mucosal invasion of the mesenchymal layer (E), which contrasts with relatively
normal squamous differentiation (D) in many areas. (F) Radial asymmetry
of E18.5 ShhCre/+;Catnb+/lox(ex3) esophagus,
with squamous (blue arrowheads) and cuboidal (green arrowheads) epithelia on
opposite surfaces. (G) Magnification of the area boxed in F. PAS
staining reveals many cells abnormally producing mucin in the cuboidal
epithelium of the esophagus. (H-J) Although intestinal villi are
absent, there is considerable and ectopic expression of the intestinal marker
Cdx2 (H,I), which is normally excluded from the squamous (J) and glandular
(data not shown) stomach. H is a magnification of the area boxed in C.
|
|

View larger version (71K):
[in this window]
[in a new window]
|
Fig. 5. Abnormal spleen development in Barx1-/- mice.
(A) Relationship of the spleen (Sp) in normal neonatal mice to adjacent
stomach (St), duodenum (Du) and a fused pancreas (Pa). (B) Invariant
size and location of the Barx1-/- spleen as a small tissue
(marked with a dotted line) attached to the dorsal pancreas, which is separate
from the ventral pancreatic bud. (C,D) Histologic elucidation of
intimate association between splenic and pancreatic parenchyma by H&E
stain (C) and insulin immunostaining of prospective pancreatic islets (D,
arrowheads) on consecutive tissue sections. (E) Flow cytometric (left)
and immunohistochemical (right) analysis of control (+/?) and
Barx1-/- spleen (Sp), indicating normal hematopoiesis and
lymphoid colonization (+/? refers to +/+ or +/-). Ter119, B220 and Gr1 are
specific markers of red cells, B lymphocytes and granulocytes, respectively.
Control and Barx1-/- spleen also showed identical flow
cytometry profiles for T-cell and monocyte surface markers (data not
shown).
|
|

View larger version (79K):
[in this window]
[in a new window]
|
Fig. 6. Correlates of spleen development and Barx1 expression.
(A,B) The spleen (*) appears to be specified
correctly in E9.5 Barx1-/- mouse embryos (B), as in
control littermates (A). St, stomach; Pa, pancreas. (C,D)
Differences in size and organ relationships between control (C) and
Barx1-/- (D) embryos are evident by E12.5 and increase
thereafter. The position of the mutant spleen is again highlighted with a
dotted line in D. (E-G) Radioactive mRNA in situ hybridization at
E10.5, E11.5 and E13.5, showing high Barx1 expression in stomach
mesenchyme and mesothelium with exclusion from spleen mesenchyme throughout.
Bright-field images are shown for the younger embryos and a dark-field image
at E13.5. (H,I) Colorimetric mRNA in situ hybridization at
E12.5, showing absence of Barx1 expression in intestinal (Int;
arrowheads in H) mesentery and presence in the mesothelial lining of the
caudal liver (Lv; arrowheads in I), adjacent to the stomach (St).
(J,K) Immunohistochemical confirmation with Barx1 (J) and
preimmune (K) antiserum of high expression in stomach mesenchyme (top) and
mesothelium (arrowheads), with exclusion from the spleen (Sp) mesenchyme in
E12.5 embryos.
|
|

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 7. Barx1 effects on the spleen are not mediated through either Wnt
signaling or a group of homeodomain transcription factors implicated in
control of spleen development. (A-C) Lack of ß-gal activity in
the pancreas or spleen of Barx1-/-;TOPGAL E18.5 mouse
embryos, shown in situ (A) to contrast with residual activity in the stomach
(St) and native signal in duodenum (Du). The dotted line in A marks the fused
spleen-pancreas (Pa), where absence of ß-gal activity is further revealed
in B and confirmed by microscopic analysis in C. (D) In contrast to
Barx1, homeobox genes previously implicated in spleen development are
mostly expressed in prospective spleen mesenchyme (Sp) and excluded from the
mesothelium. The left column shows low-magnification images from each in situ
hybridization, and the boxed area of each image is shown at higher
magnification in the middle column, where the splenic capsule is demarcated by
dotted lines. Images in the right-hand column reveal that expression of each
of these homeobox genes is maintained in Barx1-/- spleen,
which is recognized in part by juxtaposition to Pdx1+ pancreatic
tissue (red box).
|
|

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 8. Reduced expression of the multifunctional zinc-finger protein Wt1 in
spleen mesothelium of Barx1-/- mice. (A) Among
the genes previously implicated in spleen development, only expression of
Wt1 is readily recognized in the mesothelial lining (arrowheads) of
wild-type E13.5 stomach (St) and spleen (Sp). (B) Higher magnification
images of Wt1 mRNA expression indicate enrichment in wild-type spleen
capsule (the boxed area in the left panel is shown at even higher
magnification in the middle panel, where arrowheads point to the outer
surface) and substantially reduced levels in Barx1-/-
spleen (right-hand panel). (C) Independent confirmation of reduced
Wt1 transcript levels, assessed by RT-PCR on RNA extracted from
isolated E13.5 spleen and surrounding mesothelium. Products of conventional
RT-PCR are shown in the gel on the left, and quantitation by real-time PCR
using different primers in the bar chart on the right. For quantitative
RT-PCR, values were first normalized for Gapdh expression and then to
a value of 1.0 for control samples (+/? refers to +/+ or +/-). (D)
Confirmation of reduced Wt1 expression by immunohistochemistry. Control (+/+)
E13.5 stomach and spleen are shown in the left-hand panels and mutant tissues
in the right-hand panels; the boxed areas in the upper panels are shown at
higher magnification in the lower panels. Arrowheads point to the mesothelium,
where Wt1 levels are reduced in Barx1-/- embryos. St,
stomach; Sp, spleen; Pa, pancreas; Kd, kidney; Lv, liver. (E) Wt1
expression in Barx1-/- E13.5 kidney is intact.
|
|
© The Company of Biologists Ltd 2007